Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments
Date:11/9/2010

266)$(34,835)$(96,293)$(123,432)Net loss per share, basic & diluted

$(0.31)$(0.38)$(0.91)$(1.51)Shares used in calculating net loss per share, basic & diluted

117,40990,995105,58281,518Arena Pharmaceuticals, Inc.Condensed Consolidated Balance Sheet Data(In thousands)September 30, 2010December 31, 2009(unaudited)*Assets  Cash, cash equivalents & short-term investments

$ 176,536$ 115,449  Accounts receivable

1,9721,415  Other current assets

3,2744,409  Land, property & equipment, net

93,08195,445  Acquired technology & other non-current assets

18,17719,560Total assets

$ 293,040$ 236,278Liabilities and Stockholders' Equity  Accounts payable and accrued liabilities

$   13,762$   15,884  Total deferred revenues

49,0464,086  Total derivative liabilities

1,7856,642  Total note payable to Siegfried

9,8889,143  Total note payable to Deerfield**35,43447,906  Total lease financing obligations & other long-term liabilities

77,41978,050  Total stockholders' equity

105,70674,567Total liabilities & stockholders' equity

$ 293,040$ 236,278* The condensed consolidated balance sheet data as of December 31, 2009, has been derived from the audited financial statements as of that date.

** The outstanding principal balance of the note payable to Deerfield was $60.0 million and $90.0 million at September 30, 2010 and December 31, 2009, respectively.


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes
2. Endologix Announces Publication of Clinical Trial Results Supporting Anatomical Fixation with a Suprarenal Aortic Extension
3. Arena and Eisai Announce Upcoming Lorcaserin Presentations at Obesity 2010
4. Arena and Eisai Provide Update on Lorcaserin FDA Advisory Committee Meeting
5. Arena Pharmaceuticals to Host Conference Call and Webcast Following Lorcaserin FDA Advisory Committee Meeting
6. Arena Pharmaceuticals Submits New Drug Application to FDA for Lorcaserin for Weight Management
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
9. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, November 10, 2009
10. Arena Pharmaceuticals Lorcaserin to be Featured in Multiple Presentations at Obesity 2009
11. Arena Pharmaceuticals Reports Positive, Highly Significant BLOSSOM Trial Results for Weight Management; NDA Submission on Track for December
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Sept. 1, 2015  AccuTec Blades, Inc. today announced ... Blades division.  EPC announced in May 2015 its intent ... Verona, Virginia and Obregon, Mexico ... sale process. Rick Gagliano , ... Blades said, "Our new name, AccuTec Blades, reflects the ...
(Date:9/1/2015)... FREMONT, Calif. , Sept. 1, 2015 /PRNewswire/ ... clinical-stage biopharmaceutical company focused on gastrointestinal and cardio-renal ... its termination of the option and license agreement ... 30, 2015. There was no payment associated with ... In February 2014, Ardelyx and Sanofi entered into ...
(Date:9/1/2015)... SALT LAKE CITY , Sept. 1, 2015 ... announced that it will present at the First ... Hotel in New York City.  Kelvyn H. ... to present to leading institutional investment representatives on ... The Ladenburg Thalmann Conference will showcase ...
Breaking Medicine Technology:AccuTec Blades, Inc. Announces Acquisition of Industrial Blades Division from Edgewell Personal Care Company 2Ardelyx Regains NaP2b Program from Sanofi 2Ardelyx Regains NaP2b Program from Sanofi 3
... introduces its service to the Rocky Mountain ... Greater Denver,s leading doctors, including those affiliated with ... provides patients with their choice of thousands of ... dermatologists and eye doctors throughout the Denver metropolitan ...
...  Unigene Laboratories, Inc. (OTCBB: UGNE) a ... of peptide-based therapeutics today reported positive data from ... for its lead proprietary anorexigenic peptide, UGP281.  ... targeting the amylin receptor, is under development by ...
Cached Medicine Technology:Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 2Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 3Denver Patients Can Now Easily Find Doctors and Schedule Appointments Online 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 2Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 3Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 5
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... From ... 86 children and teenagers, from ages 6-18. Calvary’s Camp Compass® has taken place at ... staff included 65 adult counselors, some of whom work for Calvary, and two junior ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... options to efficiently cure and prevent different malignancies. Some options for cancer ... pathophysiological properties due to which distinctive approach is necessary for effective treatment. ...
(Date:9/1/2015)... ... 2015 , ... Negative pressure wound therapy (NPWT) entails the ... exudates, fluid, and infectious materials to prepare the wound for healing and closure. ... canisters, etc.) is projected to expand continuously through 2021. , Rising patient and ...
(Date:9/1/2015)... Florida (PRWEB) , ... September ... ... of Professional Background Screeners (NAPBS®) has announced that Edge Information Management ... conducted by the Background Screening Credentialing Council (BSCC). , “Achieving and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, a leading global ... that it has hired Scott Sanderson, an experienced business development professional and former ... be responsible for establishing and managing new client relationships in the Southeast U.S. ...
Breaking Medicine News(10 mins):Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 2Health News:Calvary Hospital Hosts 18th Annual Bereavement Camp 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... July 31 With the world,s,attention focused on ... Miracles -- a 30-minute Sunday morning public affairs ... of real,patients -- will feature two of America,s ... Jenner. Sharing Miracles now shows on 158,television stations ...
... VANCOUVER, July 31 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced ... in Arlington Virginia. This Center is the Company,s first ... markets that CRH has targeted for,expansion. The opening of ... bringing the Company,s total number of Centers to 17., ...
... July 31 The American Association,of PPOs (AAPPO) ... course",for PPO executives on strategies to improve the ... AAPPO Adding Value Initiative will inform AAPPO,members and ... outcomes., (Logo: http://www.newscom.com/cgi-bin/prnh/20060126/CLTH062LOGO ), ...
... Policies Needed, WASHINGTON, July 31 As the ... convening of the,International AIDS Conference in Mexico City, the ... to announce on August 3rd,significantly higher HIV incidence numbers ... infections per year; the new number may be,more than ...
... number of unusual chromosomal changes, particularly structural changes that ... genes. These results were published today in the scientific ... in the structure of the genes in patients with ... number variants. Genetic diseases are caused by a large ...
... an increased risk of developing cardiovascular disease, particularly stroke ... Atherosclerosis , has now led to attempts to ... (hardening of the arteries) is an inflammatory disease in ... and become less elastic. It can cause blood clots ...
Cached Medicine News:Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 2Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 3Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 4Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 5Health News:'Sharing Miracles' Television Program to Feature Olympic Legends Mark Spitz and Bruce Jenner 6Health News:CRH Medical Corporation opens center in Virginia 2Health News:AAPPO Launches Short Course Conference Call Series on Value-added Strategies for PPOs 2Health News:Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government 2Health News:Unusual chromosomal changes increase the risk of schizophrenia 2Health News:New discovery may lead to immunization against cardiovascular disease 2
Reusable, stainless steel trephine with handle....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Medicine Products: